Provided by Tiger Trade Technology Pte. Ltd.

Merck

144.71
-2.8200-1.91%
Post-market: 144.65-0.0600-0.04%19:57 EDT
Volume:7.54M
Turnover:1.09B
Market Cap:357.02B
PE:113.69
High:148.00
Open:147.94
Low:144.10
Close:147.53
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:0.95
T/O Rate:0.31%
Dividend:3.32
Dividend Rate:2.29%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.51
PE(LYR):19.88

Loading ...

Jefferies Adjusts Price Target on Merck & Co. to $152 From $147, Keeps Buy Rating

MT Newswires Live
·
Aug 04

Merck Beats Q2 Revenue Estimates, Raises FY Revenue Outlook

Reuters
·
Aug 04

Merck & Co Q2 Gardasil Revenue USD 1,169 Million

THOMSON REUTERS
·
Aug 04

Merck cuts FY26 adjusted EPS view to $2.66-$2.76 from $5.04-$5.16

TIPRANKS
·
Aug 04

Morning BID Americas-Earnings Overload

Reuters
·
Aug 04

Merck reports Q2 adjusted EPS (13c), consensus (26c)

TIPRANKS
·
Aug 04

Merck Shares up 2.6% After Q2 Revenue Beat

THOMSON REUTERS
·
Aug 04

GUIDANCE: (MRK) Merck Expects 2026 Adjusted EPS Range $2.66 - $2.76 vs. FactSet Est of $2.79

MT Newswires Live
·
Aug 04

Movement Alert|Merck Rises 3.31% in Pre-Market Trading, Earnings Day Combined with Jefferies Target Price Upgrade

Market Focus
·
Aug 04

Merck & Co Q2 Adj. EPS $(0.13) Beats $(0.27) Estimate, Sales $16.607B Beat $16.356B Estimate

Benzinga Earnings
·
Aug 04

Merck & Co Q2 Keytruda Revenue USD 8,400 Million

THOMSON REUTERS
·
Aug 04

Merck & Co., Inc., Rahway, N.j., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline

THOMSON REUTERS
·
Aug 04

Merck Outlook FY Worldwide Sales $66.3 Bln to $67.3 Bln vs Ibes Estimate $66.83 Bln

THOMSON REUTERS
·
Aug 04

Merck: Q2 Adj Loss/Share Includes Charge of $2.31/Share for Acquisition of Terns

THOMSON REUTERS
·
Aug 04

Merck Outlook FY Non-Gaap Operating Expenses $42 Bln to $42.7 Bln

THOMSON REUTERS
·
Aug 04

Merck Q2 Keytruda Sales $8.37 Bln vs Ibes Estimate $8.08 Bln

THOMSON REUTERS
·
Aug 04

Merck Outlook FY Adj EPS $2.66 to $2.76 vs Ibes Estimate $2.76

THOMSON REUTERS
·
Aug 04

Merck Q2 Adj EPS $-0.13 vs Ibes Estimate $-0.27

THOMSON REUTERS
·
Aug 04

Merck Delivers a Clean Earnings Beat on Oncology Strength. is it Enough to Impress Wall Street?

Dow Jones
·
Aug 04

Merck Posts Better-than-Expected Second-Quarter Results on Keytruda Strength

Reuters
·
Aug 04